VRDN icon

Viridian Therapeutics
VRDN

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $303K invested in Viridian Therapeutics in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$11K
2
+$6K
3
+$1K

Top Sellers

1
-$14.4K
2
-$12K
3
-$9.58K
4
UBS Group
UBS Group
Switzerland
-$9K
5
PCM
Perkins Capital Management
Minnesota
-$6.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$174K
2
$44K
3
$30K
4
$16K
5
$15K
6
$11K
7
$6K
8
$6K
9
$1K
10
–
11
–
12
–